bioAffinity Technologies, Inc. (BIAF) - Latest Market Data

Price & Market Data

Price: $1.63

Daily Change: +$0.0119 / 0.73%

Daily Range: $1.56 - $1.78

Market Cap: $7,074,453

Daily Volume: 113,610

Performance Metrics

1 Week: -13.67%

1 Month: -37.45%

3 Months: 41.67%

6 Months: 21.88%

1 Year: -79.23%

YTD: 38.13%

About bioAffinity Technologies, Inc. (BIAF)

Quick market take on bioAffinity Technologies, Inc. (BIAF). Current price: 1.63, daily change: +$0.0119 / 0.73%. Market cap: 7,074,453. Performance over 1-week and 1-month.

Company Details

Employees: 57

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. The company has a collaboration with Brooke Army Medical Center to evaluate its proprietary tests under development to identify inflammatory biomarkers for asthma and chronic obstructive pulmonary disease. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Selected stocks

Atlantic American Corporation (AAME)

NN, Inc. (NNBR)

Banco Bradesco Sa (BBD)

NextNRG, Inc. (NXXT)

Unifi, Inc. New (UFI)